C5 and chlamydia trachomatis infectious disease: To evaluate whether NM could inhibit the C3-independent C5 activation triggered by chlamydial infection, NM (400 μM) was pre-mixed with different dilutions of C. trachomatis-HeLa229 cell lysates followed by co-incubation with purified C5 protein.